European Cancer Organisation
login
close
Forgot password

* Mandatory fields

Create account

Flims Alumni Club

Who are we?

The Flims Alumni Club (FAC) an Advisory Member of ECCO - the European CanCer Organisation, is a non-profit organisation that was established in 2001.

The FAC responds to the interests and needs of highly driven European junior clinical oncologists by offering an expanding range of benefits exclusive to Members.

FAC Membership is free and open solely to young professionals and Faculty who have participated in the ECCO-AACR-EORTC-ESMO Workshops on ‘Methods in Clinical Cancer Research’.

FAC Members enjoy exclusive access to the FAC Members Directory and a direct networking opportunity via the Flims Alumni Club LinkedIn Group.

FAC Membership also entitles you to especially reduced fees to attend key meetings such as the European Multidisciplinary Cancer Congress, which incorporates a Young Oncologists Track, as well as FAC events and workshops.

Click here to view the complete list of FAC Membership benefits.

Join and follow the Flims Alumni Club on LinkedIn and Twitter and keep up-to-date with the latest news and announcements!

 

 

IMPORTANT NEWS: The Flims Alumni Club (FAC) Workshop & Networking Meeting

The FAC Steering Committee is pleased to announce the 2nd edition of the FAC Workshop to be held at the European Cancer Congress, Amsterdam on Monday 30 September from 09:00-15:00

In line with its mission to provide a forum to disseminate accurate information, address issues relevant to young cancer specialists, and develop a sense of community by fostering interactions among its members. This Workshop will start with an introduction followed by three highly educational and informative lecture sessions & discussions...READ MORE

 

Tribute to Professor George Vlastos

It is with the deepest sadness and sorrow that we announce the death of our friend and past FAC Treasurer, Professor George Vlastos, who passed away on Friday 8 February 2013.

Our thoughts are with his family and loved ones, and we would like to pay tribute to Professor Vlastos' achievements and contribution to the field of oncology.

PRINT THIS PAGE